Search by Drug Name or NDC
NDC 73289-0065-02 MOTPOLY XR 200 mg/1 Details
MOTPOLY XR 200 mg/1
MOTPOLY XR is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aucta Pharmaceuticals, Inc.. The primary component is LACOSAMIDE.
Product Information
| NDC | 73289-0065 |
|---|---|
| Product ID | 73289-0065_0d087b93-b0a2-5cf9-e063-6294a90aa058 |
| Associated GPIs | |
| GCN Sequence Number | 084747 |
| GCN Sequence Number Description | lacosamide CAP ER 24H 200 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 54122 |
| HICL Sequence Number | 035872 |
| HICL Sequence Number Description | LACOSAMIDE |
| Brand/Generic | Brand |
| Proprietary Name | MOTPOLY XR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lacosamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | LACOSAMIDE |
| Labeler Name | Aucta Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | CV |
| Marketing Category | NDA |
| Application Number | NDA216185 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 73289-0065-02 (73289006502)
| NDC Package Code | 73289-0065-2 |
|---|---|
| Billing NDC | 73289006502 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0065-2) |
| Marketing Start Date | 2023-05-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |